Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing
Molecular Diagnosis & Therapy · 2024-05 · 28 (3) · 301-310
DOI: 10.1007/s40291-024-00698-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, online erschienen am 08.03.2024. Verfasst von Filip Šustr und 8 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, St. Anne's University Hospital in Brno and Faculty of Medicine of Masaryk University, Pekařská 53, 602 00, Brno,…. Hauptthemen laut MEDLINE: Atrial Fibrillation, MicroRNAs, Catheter Ablation, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fakultni Nemocnice u Svaté Anny v Brně, Ministerstvo Školství, Mládeže a Tělovýchovy, European Union Next Generation.
Abstract (Originalsprache)
Background
Catheter ablation (CA) of atrial fibrillation (AF) is indicated in patients with recurrent and symptomatic AF episodes. Despite the strict inclusion/exclusion criteria, AF recurrence after CA remains high. Identification of a novel biomarker that would predict AF recurrence would help to stratify the patients. The aim of the study was to seek novel biomarkers among the plasmatic microRNAs (miRNAs, miRs).
Methods
A prospective monocentric study was conducted. A total of 49 consecutive AF patients indicated for CA were included. Blood sampling was performed prior to CA. RNA was isolated from plasma using commercial kits. In the exploration phase, small RNA sequencing was performed in ten AF patients (five with and five without AF recurrence) using Illumina instrument. In the validation phase, levels of selected miRNAs were determined using quantitative reverse transcription polymerase chain reaction (qRT-PCR) in all participants.
Results
Altogether, 22 miRNAs were identified as altered between the groups by next-generation sequencing (using the DESeq2 algorithm). Using qRT-PCR, levels of the five most altered miRNAs (miR-190b/206/326/505-5p/1296-5p) were verified in the whole cohort. Plasma levels of hsa-miR-206 were significantly higher in patients with early (within 6 months) AF recurrence and showed an increase of risk recurrence,2.65 times by every increase in its level by 1 unit in the binary logistic regression.
Conclusion
We have identified a set of 22 plasmatic miRNAs that differ between the patients with and without AF recurrence after CA and confirmed hsa-miR-206 as a novel miRNA associated with early AF recurrence. Results shall be verified in a larger independent cohort. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 2nd Department of Internal Medicine, St. Anne's University Hospital in Brno and Faculty of Medicine of Masaryk University, Pekařská 53, 602 00, Brno, Czech Republic.
- Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Ondrej Slaby Joint Research Group, Central European Institute of Technology and Department of Biology of Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 1st Department of Internal Medicine, Cardioangiology, St. Anne's University Hospital in Brno and Faculty of Medicine of Masaryk University, Brno, Czech Republic.
- 2nd Department of Internal Medicine, St. Anne's University Hospital in Brno and Faculty of Medicine of Masaryk University, Pekařská 53, 602 00, Brno, Czech Republic. jan.novak@fnusa.cz.
- Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. jan.novak@fnusa.cz.
Förderung
- Fakultni Nemocnice u Svaté Anny v Brně
- Ministerstvo Školství, Mládeže a Tělovýchovy
- European Union Next Generation
- Masaryk University
Zitieren
APA
Šustr, F., Macháčková, T., Pešl, M., Svačinova, J., Trachtová, K., Stárek, Z., Kianička, B., Slabý, O., & Novák, J. (2024). Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing. Molecular Diagnosis & Therapy, 28(3), 301-310. https://doi.org/10.1007/s40291-024-00698-x
Vancouver
Šustr F, Macháčková T, Pešl M, Svačinova J, Trachtová K, Stárek Z, et al. Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing. Molecular Diagnosis & Therapy. 2024;28(3):301-310. doi:10.1007/s40291-024-00698-x
BibTeX
@article{ustr2024,
author = {Šustr, Filip and Macháčková, Táňa and Pešl, Martin and Svačinova, Jana and Trachtová, Karolína and Stárek, Zdeněk and Kianička, Bohuslav and Slabý, Ondřej and Novák, Jan},
title = {Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing},
journal = {Molecular Diagnosis & Therapy},
year = {2024},
volume = {28},
number = {3},
pages = {301--310},
doi = {10.1007/s40291-024-00698-x}
}
EUVIMED